Jennifer Schranz - Net Worth and Insider Trading

Jennifer Schranz Net Worth

The estimated net worth of Jennifer Schranz is at least $0 dollars as of 2024-09-20. Jennifer Schranz is the Chief Medical Officer of Nabriva Therapeutics PLC and owns about 22 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Jennifer Schranz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Schranz has not made any transactions after 2018-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jennifer Schranz

To

Jennifer Schranz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Schranz owns 1 companies in total, including Nabriva Therapeutics PLC (NBRVF) .

Click here to see the complete history of Jennifer Schranz’s form 4 insider trades.

Insider Ownership Summary of Jennifer Schranz

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2018-06-22 Chief Medical Officer

Jennifer Schranz Latest Holdings Summary

Jennifer Schranz currently owns a total of 1 stock. Jennifer Schranz owns 22 shares of Nabriva Therapeutics PLC (NBRVF) as of June 22, 2018, with a value of $0.

Latest Holdings of Jennifer Schranz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBRVF Nabriva Therapeutics PLC 2018-06-22 22 0.00 0

Holding Weightings of Jennifer Schranz


Jennifer Schranz Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer Schranz has made a total of 0 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years. The most-recent trade in Nabriva Therapeutics PLC is the acquisition of 22 shares on June 22, 2018, which cost Jennifer Schranz around $20,515.

Insider Trading History of Jennifer Schranz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer Schranz Trading Performance

GuruFocus tracks the stock performance after each of Jennifer Schranz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Schranz is -33.77%. GuruFocus also compares Jennifer Schranz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Schranz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer Schranz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer Schranz

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Jennifer Schranz Ownership Network

Ownership Network List of Jennifer Schranz

No Data

Ownership Network Relation of Jennifer Schranz

Insider Network Chart

Jennifer Schranz Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Jennifer Schranz is the Chief Medical Officer of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Jennifer Schranz Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Schranz. You might contact Jennifer Schranz via mailing address: 1000 Continental Drive, Suite 600, King Of Prussia Pa 19406.

Discussions on Jennifer Schranz

No discussions yet.